WMSA
Weiss Multi-Strategy Advisers’s Karyopharm Therapeutics KPTI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-27,043
| Closed | -$23K | – | 239 |
|
|
2023
Q4 | $23K | Sell |
27,043
-4,771
| -15% | -$4.06K | ﹤0.01% | 470 |
|
|
2023
Q3 | $43K | Sell |
31,814
-3,745
| -11% | -$5.07K | ﹤0.01% | 498 |
|
|
2023
Q2 | $64K | Sell |
35,559
-3,753
| -10% | -$6.75K | ﹤0.01% | 563 |
|
|
2023
Q1 | $153K | Buy |
39,312
+15,183
| +63% | +$59.1K | ﹤0.01% | 553 |
|
|
2022
Q4 | $82K | Sell |
24,129
-596
| -2% | -$1.99K | ﹤0.01% | 546 |
|
|
2022
Q3 | $135K | Sell |
24,725
-797
| -3% | -$4.34K | ﹤0.01% | 599 |
|
|
2022
Q2 | $115K | Sell |
25,522
-2,356
| -8% | -$10.7K | ﹤0.01% | 615 |
|
|
2022
Q1 | $205K | Sell |
27,878
-2,005
| -7% | -$14.7K | ﹤0.01% | 602 |
|
|
2021
Q4 | $192K | Sell |
29,883
-4,216
| -12% | -$27.1K | ﹤0.01% | 591 |
|
|
2021
Q3 | $198K | Buy |
34,099
+762
| +2% | +$4.44K | ﹤0.01% | 603 |
|
|
2021
Q2 | $344K | Buy |
33,337
+1,194
| +4% | +$12.2K | 0.01% | 561 |
|
|
2021
Q1 | $338K | Buy |
32,143
+7,047
| +28% | +$74.1K | 0.01% | 558 |
|
|
2020
Q4 | $388K | Buy |
25,096
+2,957
| +13% | +$45.7K | 0.01% | 556 |
|
|
2020
Q3 | $323K | Buy |
+22,139
| New | +$323K | 0.01% | 490 |
|
|
2020
Q2 | – | Sell |
-10,604
| Closed | -$204K | – | 556 |
|
|
2020
Q1 | $204K | Sell |
10,604
-4,396
| -29% | -$84.5K | 0.01% | 374 |
|
|
2019
Q4 | $288K | Sell |
15,000
-10,000
| -40% | -$192K | ﹤0.01% | 486 |
|
|
2019
Q3 | $241K | Hold |
25,000
| – | – | ﹤0.01% | 430 |
|
|
2019
Q2 | $150K | Hold |
25,000
| – | – | ﹤0.01% | 391 |
|
|
2019
Q1 | $146K | Hold |
25,000
| – | – | ﹤0.01% | 409 |
|
|
2018
Q4 | $234K | Buy |
25,000
+4,905
| +24% | +$45.9K | 0.01% | 336 |
|
|
2018
Q3 | $342K | Buy |
20,095
+95
| +0.5% | +$1.79K | 0.01% | 386 |
|
|
2018
Q2 | $340K | Buy |
+20,000
| New | +$340K | 0.01% | 402 |
|